Immix Biopharma, Inc. (IMMX)

Immix Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.68	17.51	13.44	17.64	0.39
Cash & Short-Term Investments	17.68	17.51	13.44	17.64	0.39
Cash Growth	0.98%	30.31%	-23.85%	4411.66%	-46.72%
Other Receivables	1.97	1.17	0.26	0.03	0.13
Receivables	1.97	1.17	0.26	0.03	0.13
Prepaid Expenses	0.51	1.06	1.13	0.52	0.01
Other Current Assets	0.03	0.04	0.08	-	-
Total Current Assets	20.2	19.79	14.9	18.19	0.53
Property, Plant & Equipment	2.73	0.05	0	0.01	0.01
Long-Term Deferred Charges	-	0.09	0.01	-	-
Other Long-Term Assets	0.02	-	-	-	-
Total Assets	22.95	19.93	14.91	18.19	0.54
Accounts Payable	5.39	1.43	0.14	0.14	0.25
Accrued Expenses	3.23	2.29	1.13	0.01	0.34
Short-Term Debt	-	-	-	0.05	0.05
Current Portion of Long-Term Debt	-	-	-	-	4.05
Current Portion of Leases	0.07	-	-	-	-
Other Current Liabilities	-	-	-	-	0.58
Total Current Liabilities	8.69	3.72	1.27	0.2	5.27
Long-Term Leases	1.01	-	-	-	-
Other Long-Term Liabilities	-	-	0.48	-	-
Total Liabilities	9.7	3.72	1.75	0.2	5.27
Common Stock	0	0	0	0	0
Additional Paid-In Capital	88.37	69.78	51.16	47.62	0.51
Retained Earnings	-75.02	-53.41	-37.99	-29.76	-5.37
Treasury Stock	-0.1	-0.1	-0.1	-	-
Comprehensive Income & Other	-0	0.13	0.09	0.13	0.13
Total Common Equity	13.25	16.41	13.16	17.99	-4.73
Minority Interest	-	-0.2	-	-	-
Shareholders' Equity	13.25	16.2	13.16	17.99	-4.73
Total Liabilities & Equity	22.95	19.93	14.91	18.19	0.54
Total Debt	1.07	-	-	0.05	4.1
Net Cash (Debt)	16.61	17.51	13.44	17.59	-3.71
Net Cash Growth	-5.16%	30.31%	-23.63%	-	-
Net Cash Per Share	0.59	1.01	0.97	4.79	-1.10
Filing Date Shares Outstanding	27.72	26.4	13.9	13.86	3.38
Total Common Shares Outstanding	27.54	19.92	13.89	13.23	3.38
Working Capital	11.51	16.07	13.62	17.98	-4.74
Book Value Per Share	0.48	0.82	0.95	1.36	-1.40
Tangible Book Value	13.25	16.41	13.16	17.99	-4.73
Tangible Book Value Per Share	0.48	0.82	0.95	1.36	-1.40
Machinery	0.85	0.06	-	-	-
Construction In Progress	0.94	-	-	-	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q